Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rasha E Boulos

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMC Bioinformatics|April 13, 2017
Multi-scale structural community organisation of the human genomeRasha E Boulos, Nicolas Tremblay, Alain Arneodo, et al.
FEBS Letters|April 28, 2015
Structural organization of human replication timing domainsRasha E Boulos, Guénola Drillon, Françoise Argoul, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2022
Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapyMarion Mallet, Rasha E Boulos, Vincent Alcazer, et al.
Computational Biology and Chemistry|September 17, 2014
Large replication skew domains delimit GC-poor gene deserts in humanLamia Zaghloul, Guénola Drillon, Rasha E Boulos, et al.
BMC Infectious Diseases|April 2, 2022
SARS-CoV-2 historical global testing and genomic variabilityHalim Tannous, Shadi Akiki, Rasha E Boulos, et al.
Science Advances|January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapyPaola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.
Nature Communications|December 2, 2021
Cross-species analysis of viral nucleic acid interacting proteins identifies TAOKs as innate immune regulatorsFriederike L Pennemann, Assel Mussabekova, Christian Urban, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancerPaola Bonaventura, Audrey Page, Olivier Tabone, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMC Bioinformatics|April 13, 2017
Multi-scale structural community organisation of the human genomeRasha E Boulos, Nicolas Tremblay, Alain Arneodo, et al.
FEBS Letters|April 28, 2015
Structural organization of human replication timing domainsRasha E Boulos, Guénola Drillon, Françoise Argoul, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2022
Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapyMarion Mallet, Rasha E Boulos, Vincent Alcazer, et al.
Computational Biology and Chemistry|September 17, 2014
Large replication skew domains delimit GC-poor gene deserts in humanLamia Zaghloul, Guénola Drillon, Rasha E Boulos, et al.
BMC Infectious Diseases|April 2, 2022
SARS-CoV-2 historical global testing and genomic variabilityHalim Tannous, Shadi Akiki, Rasha E Boulos, et al.
Science Advances|January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapyPaola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.
Nature Communications|December 2, 2021
Cross-species analysis of viral nucleic acid interacting proteins identifies TAOKs as innate immune regulatorsFriederike L Pennemann, Assel Mussabekova, Christian Urban, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancerPaola Bonaventura, Audrey Page, Olivier Tabone, et al.
Pageof 1